Kumar , D. and Pandey , P.R. and Kundu , G.C. (2017) Notch1-MAPK signaling axis is essential in CD133+ melanoma initiating cells. Journal of Cell Signaling, 2 (4). p. 4.

Preview

Text 35.Dr. Kundu (J Cell Signaling) open access.pdf Download (388Kb) | Preview

Abstract

Human malignant melanoma is highly aggressive and metastatic in nature and exhibits phenotypic plasticity. Melanoma has multiple phenotypically distinct subpopulations which involved in tumor progression and markedly resistant to conventional therapy. Some of the melanoma subpopulation exhibits stem cells feature and defined as cancer stem cells (CSCs) or tumor initiating cells (TICs). Identification and characterization of CSCs in melanoma may have therapeutic implication for combating melanoma progression. In recent study, we have identified that CD133+ subpopulation of melanoma potentially involved in tumor initiation, metastasis, epithelial to mesenchymal (EMT) and angiogenesis. Genetic and pharmacological screening revealed that functional properties of CD133+ melanoma cells are regulated by Notch1-MAPK signaling axis. Andrographolide (herbal product) abrogates Notch1-MAPK pathway in CD133+ cells that leads to attenuation of melanoma progression, metastasis and angiogenesis.

Item Type:	Article
Subjects:	Cancer Biology
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	13 Dec 2018 11:32
Last Modified:	11 Feb 2021 10:03
URI:	http://nccs.sciencecentral.in/id/eprint/544

Actions (login required)

View Item